Papulopustular Rosacea
36
1
1
28
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
19 trials with published results (53%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
5.6%
2 terminated out of 36 trials
93.3%
+6.8% vs benchmark
39%
14 trials in Phase 3/4
68%
19 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (36)
Study to Evaluate the Safety of ATR-04
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
Deucravacitinib Rosacea
A Safety and Efficacy Study to Evaluate Rosacea
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea
Study of TP-04 in Participants With Papulopustular Rosacea
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
Photodynamic Therapy for Papulopustular Rosacea
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea
A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea
A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea